| Fund |
Firm |
Onset |
AUM |
| Two SEAS Global Master Fund LP |
Two SEAS Capital LP |
2021 |
2,440.2 M |
| Altarock Fund LP |
Altarock Partners LP |
2012 |
2,412.3 M |
| Venrock Healthcare Capital Partners EG LP |
VR Adviser LLC |
2021 |
2,404.0 M |
| Commodore Capital Master LP |
Commodore Capital LP |
2019 |
2,369.3 M |
| TSG8 LP |
TSG Consumer Partners LP |
2019 |
2,233.4 M |
| Divisadero Street Partners LP |
Divisadero Street Capital Management LP |
2021 |
2,222.0 M |
| Oceana Master Fund Ltd |
Pentwater Capital Management LP |
2013 |
2,187.7 M |
| Rock Springs Capital Master Fund LP |
Rock Springs Capital Management LP |
2014 |
2,115.2 M |
| Pentwater Equity Opportunities Master Fund Ltd |
Pentwater Capital Management LP |
2013 |
1,984.0 M |
| Braidwell Partners Master Fund LP |
Braidwell LP |
2021 |
1,970.4 M |
| TCG Crossover Fund I LP |
TCG Crossover Management LLC |
2021 |
1,914.1 M |
| Braidwell Partners LP |
Braidwell LP |
2021 |
1,889.4 M |
| Anson Investments Master Fund LP |
Anson Funds Management LP |
2012 |
1,790.5 M |
| Irenic Capital Evergreen Master Fund LP |
Irenic Capital Management LP |
2022 |
1,743.2 M |
| TCG Crossover Fund II LP |
TCG Crossover Management LLC |
2024 |
1,713.9 M |
| Affinity Healthcare Fund LP |
Affinity Asset Advisors LLC |
2021 |
1,691.1 M |
| Coliseum Capital Partners LP |
Coliseum Capital Management LLC |
2012 |
1,675.6 M |
| GCM Grosvenor Special Opportunities Master Fund Ltd |
GCM Grosvenor LP |
2015 |
1,669.6 M |
| Quinn Opportunities Master LP |
Quinn Opportunity Partners LLC |
2019 |
1,622.1 M |
| TSG8 Parallel LP |
TSG Consumer Partners LP |
2019 |
1,509.3 M |
| Echinus Partners LP |
Echinus Advisors LLC |
2013 |
1,392.1 M |
| Warburg Pincus Private Equity Xi LP |
Warburg Pincus LLC |
2013 |
1,381.1 M |
| Frazier Life Sciences XII LP |
Frazier Life Sciences Management LP |
2025 |
1,350.6 M |
| Saba Capital Bluebird Fund Ltd |
Saba Capital Management LP |
2022 |
1,195.4 M |
| Sofinnova Bioequities Enhanced Master Fund LP |
Sofinnova Investments Inc |
2023 |
1,194.9 M |
| ADAR1 Partners LP |
ADAR1 Capital Management LLC |
2024 |
1,179.9 M |
| GCM Grosvenor Strategic Credit LP |
GCM Grosvenor LP |
2020 |
1,134.6 M |
| Frazier Life Sciences Xi LP |
Frazier Life Sciences Management LP |
2022 |
1,107.8 M |
| Glazer Enhanced Fund LP |
Glazer Capital LLC |
2012 |
1,105.6 M |
| Longitude Venture Partners IV LP |
Longitude Capital Management Co LLC |
2020 |
1,052.9 M |
| Whitefort Capital Master Fund LP |
Whitefort Capital Management LP |
2017 |
1,051.1 M |
| Baronx II LP |
Baron Capital Management Inc |
2025 |
1,048.6 M |
| Concentric 150 Fund LP |
Concentric Capital Strategies LP |
2024 |
1,036.1 M |
| Oncology Impact Fund 2 LP |
MPM Asset Management LLC |
2020 |
1,002.8 M |
| Khrom Investments Fund LP |
Khrom Capital Management LLC |
2014 |
980.6 M |
| Caledonia Co-Invest Master Fund LP |
Caledonia US LP |
2017 |
956.8 M |
| Trails Edge Biotechnology Master Fund LP |
Trails Edge Capital Partners LP |
2025 |
933.4 M |
| Fourthstone Master Opportunity Fund Ltd |
Fourthstone LLC |
2019 |
929.3 M |
| Kryger Enhanced Master Fund Limited |
Kryger Capital LLC |
2021 |
927.6 M |
| Map 204 A Segregated Portfolio of LMA SPC |
Lighthouse Investment Partners LLC |
2017 |
882.1 M |
| SilverArc Capital Alpha Fund II LP |
SilverArc Capital Management LLC |
2019 |
881.4 M |
| Saba Capital CEF Opportunities 1 Ltd |
Saba Capital Management LP |
2016 |
876.3 M |
| Timucuan Fund LP |
Timucuan Asset Management Inc |
2012 |
871.5 M |
| Ya II PN Ltd |
Yorkville Advisors Global LP |
2016 |
856.8 M |
| Sphera Master Fund LP |
Sphera Funds Management Ltd |
2021 |
849.7 M |
| KG Investments Fund LLC |
KG Funds Management LLC |
2012 |
844.4 M |
| Pamplona Equity Partners LP |
Pamplona Capital Management LLC |
2022 |
833.1 M |
| Castle Advisers LP |
Baron Capital Management Inc |
2012 |
818.5 M |
| Alta Fox Opportunities Fund LP |
Alta Fox Capital Management LLC |
2020 |
815.1 M |
| Trian Partners Master Fund LP |
Trian Fund Management LP |
2012 |
805.2 M |
Prev | Page 2 | Next
|